Archive for June, 2008
« Previous EntriesWhich Is The Most Important Risk Factor For Prostate Cancer: Race, Family History, Or Baseline PSA Level?
Monday, June 16th, 2008Which Is The Most Important Risk Factor For Prostate Cancer: Race, Family History, Or Baseline PSA Level?
Compelling data is emerging about the prognostic power of a man’s baseline PSA value and in its ability to dictate risk of developing prostate cancer (CaP).
Does the baseline PSA value have the same predictive power in men who […]
Medivation Initiates Second Pivotal Phase 3 Trial Of Dimebon™ In Patients With Alzheimer’s Disease
Monday, June 16th, 2008Medivation Initiates Second Pivotal Phase 3 Trial Of Dimebon™ In Patients With Alzheimer’s Disease
Medivation, Inc. (NASDAQ: MDVN) announced it has initiated dosing of patients in its second pivotal Phase 3 trial of the investigational drug Dimebon™ in patients with mild-to-moderate Alzheimer’s disease (AD). The international, double-blind, placebo-controlled safety and efficacy study of oral Dimebon is […]
Treatment Costs Nearly Double For Hay Fever And Other Allergies
Wednesday, June 11th, 2008Treatment Costs Nearly Double For Hay Fever And Other Allergies
Americans spent $11 billion on doctors’ bills, prescription drugs, and other medical care to relieve allergy symptoms such as itchy or watery eyes, stuffy noses, wheezing, coughing, and headaches in 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. […]
Raloxifene Cuts Risk of Certain Type of Breast Cancer
Wednesday, June 11th, 2008Raloxifene Cuts Risk of Certain Type of Breast Cancer
A drug already approved to reduce the risk of breast cancer in high-risk women also seems to cut the risk for other women.
A new analysis finds that those who took raloxifene (Evista) regularly over a number of years were less likely to develop invasive estrogen-receptor (ER) […]
How Drug That Blocks Cholesterol Absorption From The Diet Works
Thursday, June 5th, 2008How Drug That Blocks Cholesterol Absorption From The Diet Works
A new study in the June issue of Cell Metabolism, a Cell Press publication, sheds light on the action of the drug ezetimibe (trade name Zetia), which is used to treat high cholesterol. Ezetimibe is unique among cholesterol-lowering drugs in that it works by cutting the […]
